Amedisys, Inc. (NASDAQ: AMED) delivered strong quarterly results for Q1 2025, seeing substantial growth in both revenue and net income. However, it faces challenges related to ongoing legal issues and the pending merger with UnitedHealth Group.
Key Financial Highlights:
Net service revenue: $594...